Switching to long-acting insulin analogs, once-daily oral medications, or agents with lower hypoglycaemic risk, such as metformin, SGLT2i or GLP-1 RA, can help reduce the complexity of diabetes management. This evidence concerns the gene INS and diabetes mellitus.